08.03.2018 12:39:00
|
Sapiens Reports Fourth Quarter and Full Year 2017 Financial Results
HOLON, Israel, March 8, 2018 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, with a growing presence in the financial services sector, and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), today announced its financial results for the fourth quarter and full year ended December 31, 2017.
Fourth Quarter 2017 Highlights:
- Revenue increases 25.4% to $71.6 million. Non-GAAP revenue increased 26.9% from the same period in the prior year to $72.4 million.
- Operating income totaled $1.1 million, down 79.8% compared to last year. Non-GAAP operating income totaled $9.1 million, up 20.9% compared to the same period in the prior year.
- Operating margin of 1.6%, compared to 9.8% last year. Non-GAAP operating margin of 12.5%, compared to 13.1% last year.
- Net income attributable to Sapiens' shareholders totaled $3.2 million. Non-GAAP net income attributable to Sapiens' shareholders totaled $6.1 million, compared to $6.0 in the same period last year.
- Diluted earnings per share of $0.07 per diluted share. Non-GAAP diluted earnings per share of $0.12 per diluted share, flat compared to the same period in the prior year.
Full Year 2017 Highlights:
- Revenue increases 24.5% to $269.2 million. Non-GAAP revenue increased 25.8% from the same period in the prior year to $272.0 million.
- Operating income totaled $1.0 million, down 96.0% from the same period in the prior year. Non-GAAP operating profit totaled $23.1 million, a decrease of 22.0% from last year.
- Operating margin of 0.4%, compared to 11.5% in the same period in the prior year. Non-GAAP operating margin of 8.5%, compared to 13.7% last year.
- Net income attributable to Sapiens' shareholders totaled $0.4 million. Non-GAAP net income attributable to Sapiens' shareholders totaled $15.5 million, a decrease of 35.8% from the same period in the prior year.
- Diluted earnings per share of $0.01 per diluted share. Non-GAAP diluted earnings per share of $0.31 per diluted share.
"We made progress in 2017 executing to our long-term strategy of becoming a leading global provider of insurance software solutions and services. We invested in acquisitions to gain rapid entrance into the US market where we acquired products and solutions, clients, personnel and resources, and strong brands in focused geographies and market segments, as well as R&D to improve our competitive advantages through internal development of products and solutions," said Roni Al-Dor, president and CEO, Sapiens. "From a growth and profitability perspective 2017 was a mixed year. We reported full year Non-GAAP revenue of $272 million, near the top of our revised 2017 guidance range, a year-over-year increase of 25.8%, primarily due to the acquisition of StoneRiver. However, we did not fully meet our 2017 expectations for profitability, with adjusted non-GAAP operating margin for the year of 8.5%."
Al-Dor concluded: "Sapiens is reiterating prior guidance for 2018 full-year revenues in the range of $280-$285 million (on a non-GAAP basis), an increase of approximately 3% to 5%. Growth is anticipated to be below prior year levels due to the elimination of certain non-core revenue, extension of the rollout time-line for a large client, certain projects that came through an acquisition that will not renew, and the loss of some revenue due to product duplication between StoneRiver and Adaptik. We are also maintaining expectations for adjusted operating margin a range of 12% to 13% (on a non-GAAP basis), based on integration, restructuring benefits, and maximizing our acquired talent."
Quarterly Results Conference Call
Management will host a conference call and webcast today, March 8 at 9:00 a.m. Eastern Time (4:00 p.m. in Israel) to review and discuss Sapiens' results.
Please call the following numbers (at least 10 minutes before the scheduled time) to participate:
North America (toll-free): + 1-888-668-9141; International: +972-3-918-0609; UK: 0-800-917-5108
The live webcast of the call can be viewed on Sapiens' website at: http://www.sapiens.com/investors/presentations-and-webcast/
If you are unable to join live, a replay of the call will be accessible until March 18, 2017, as follows:
North America: 1-888-782-4291; International: +972-3-925-5918
A recorded version of the webcast will also be available via the Sapiens website, for three months at the same location.
Non-GAAP Financial Measures
This press release contains the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP operating income, non-GAAP net income attributed to Sapiens shareholders, and non-GAAP basic and diluted earnings per share.
Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.
Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition, acquisition-related costs, restructuring and cost reduction costs, loss on sales of Marketable Securities and tax adjustment regarding non-GAAP adjustments, as well as the impact of one-time adjustment to our deferred taxes as a result of the U.S. Tax Cuts and Job act 2017.
Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.
To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.
Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.
The Company defines Adjusted EBITDA as net profit, adjusted for valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalized of software development costs, compensation expenses related to acquisition, acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business.
The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business.
About Sapiens
Sapiens International Corporation (NASDAQ and TASE: SPNS) is a leading global provider of software solutions for the insurance industry, with a growing presence in the financial services sector. We offer integrated core software solutions and business services, and a full digital suite for the property and casualty/general insurance; life, pension and annuities; and reinsurance markets. Sapiens also services the workers' compensation and financial and compliance markets.
Our portfolio includes policy administration, billing and claims; underwriting, illustration and electronic application; reinsurance and decision management software. Sapiens' digital platform features customer and agent portals, and a business intelligence platform. With a 30-year track record of delivering to more than 400 organizations, Sapiens' team of over 2,500 operates through our fully-owned subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific. For more information: www.sapiens.com.
Forward Looking Statement
Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement.
These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties, as well as certain additional risks that we face, please refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2016, and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.
SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES | |||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||
U.S. dollars in thousands (except per share amounts) | |||||||||
Three months ended | Year ended | ||||||||
December 31, | December 31, | ||||||||
2017 | 2016 | 2017 | 2016 | ||||||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | ||||||
Revenue | 71,600 | 57,113 | 269,194 | 216,190 | |||||
Cost of revenue | 45,776 | 34,648 | 175,678 | 130,402 | |||||
Gross profit | 25,824 | 22,465 | 93,516 | 85,788 | |||||
Operating expenses: | |||||||||
Research and development, net | 8,427 | 5,087 | 31,955 | 16,488 | |||||
Selling, marketing, general and administrative | 16,265 | 11,787 | 60,559 | 44,460 | |||||
Total operating expenses | 24,692 | 16,874 | 92,514 | 60,948 | |||||
Operating income | 1,132 | 5,591 | 1,002 | 24,840 | |||||
Financial expense (income), net | 1,000 | 98 | 3,010 | (533) | |||||
Taxes and other expenses, net | (3,301) | 1,383 | (2,564) | 5,772 | |||||
Net income | 3,433 | 4,110 | 556 | 19,601 | |||||
Attributable to non-controlling interest | (157) | (9) | (189) | (43) | |||||
Attributed to redeemable non-controlling interest | 43 | 7 | 43 | (134) | |||||
Adjustment to redeemable non-controlling interest | 350 | 301 | 350 | 442 | |||||
Net income attributable to Sapiens' shareholders | 3,197 | 3,811 | 352 | 19,336 | |||||
Basic earnings per share | 0.07 | 0.08 | 0.01 | 0.40 | |||||
Diluted earnings per share | 0.07 | 0.08 | 0.01 | 0.40 | |||||
Weighted average number of shares outstanding used to | 49,325 | 49,021 | 49,170 | 48,947 | |||||
Weighted average number of shares outstanding used to | 50,032 | 49,935 | 49,926 | 49,780 |
SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES | |||||||||
CONDENSED CONSOLIDATED NON-GAAP STATEMENTS OF INCOME | |||||||||
U.S. dollars in thousands (except per share amounts) | |||||||||
Three months ended | Year ended | ||||||||
December 31, | December 31, | ||||||||
2017 | 2016 | 2017 | 2016 | ||||||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | ||||||
Revenue | 72,448 | 57,113 | 272,003 | 216,190 | |||||
Cost of revenue | 42,931 | 33,263 | 165,336 | 124,423 | |||||
Gross profit | 29,517 | 23,850 | 106,667 | 91,767 | |||||
Operating expenses: | |||||||||
Research and development, net | 9,663 | 6,178 | 37,522 | 22,033 | |||||
Selling, marketing, general and administrative | 10,795 | 10,179 | 46,032 | 40,119 | |||||
Total operating expenses | 20,458 | 16,357 | 83,554 | 62,152 | |||||
Operating income | 9,059 | 7,493 | 23,113 | 29,615 | |||||
Financial expense (income), net | 1,000 | (9) | 2,780 | (640) | |||||
Taxes and other expenses | 2,033 | 1,533 | 4,940 | 6,179 | |||||
Net income | 6,026 | 5,969 | 15,393 | 24,076 | |||||
Attributable to non-controlling interest | 115 | (11) | 147 | 123 | |||||
Net income attributable to Sapiens' shareholders | 6,141 | 5,958 | 15,540 | 24,199 | |||||
Basic earnings per share | 0.12 | 0.12 | 0.32 | 0.49 | |||||
Diluted earnings per share | 0.12 | 0.12 | 0.31 | 0.49 | |||||
Weighted average number of shares outstanding used to | 49,325 | 49,021 | 49,170 | 48,947 | |||||
Weighted average number of shares outstanding used to | 50,032 | 49,935 | 49,926 | 49,780 |
SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES
RECONCILIATION OF GAAP TO NON-GAAP RESULTS
U.S. dollars in thousands (except per share amounts)
Three months ended | Year ended | ||||||||||
December 31, | December 31, | ||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||
GAAP revenue | 71,600 | 57,113 | 269,194 | 216,190 | |||||||
Valuation adjustment on acquired deferred revenue | 848 | - | 2,809 | - | |||||||
Non-GAAP revenue | 72,448 | 57,113 | 272,003 | 216,190 | |||||||
GAAP gross profit | 25,824 | 22,465 | 93,516 | 85,788 | |||||||
Revenue adjustment | 848 | - | 2,809 | - | |||||||
Amortization of capitalized software | 1,270 | 1,092 | 4,824 | 4,929 | |||||||
Amortization of other intangible assets | 1,575 | 293 | 5,518 | 1,050 | |||||||
Non-GAAP gross profit | 29,517 | 23,850 | 106,667 | 91,767 | |||||||
GAAP operating income (loss) | 1,132 | 5,591 | 1,002 | 24,840 | |||||||
Gross profit adjustments | 3,693 | 1,385 | 13,151 | 5,979 | |||||||
Capitalization of software development | (1,236) | (1,091) | (5,567) | (5,545) | |||||||
Amortization of other intangible assets | 489 | 300 | 1,725 | 1,207 | |||||||
Stock-based compensation | 655 | 522 | 2,035 | 1,955 | |||||||
Compensation related to acquisition and acquisition-related costs | 144 | 786 | 2,685 | 1,179 | |||||||
Restructuring and cost reduction plan | 4,182 | - | 8,082 | - | |||||||
Non-GAAP operating income | 9,059 | 7,493 | 23,113 | 29,615 | |||||||
GAAP net income (loss) attributable to Sapiens' shareholders | 3,197 | 3,811 | 352 | 19,336 | |||||||
Operating income (loss) adjustments | 7,927 | 1,902 | 22,111 | 4,775 | |||||||
Adjustment to redeemable non-controlling interest | 350 | 302 | 350 | 443 | |||||||
Loss on sales of Marketable Securities | - | - | 230 | - | |||||||
Tax and Other * | (5,333) | (57) | (7,503) | (355) | |||||||
Non-GAAP net income attributable to Sapiens' shareholders | 6,141 | 5,958 | 15,540 | 24,199 | |||||||
*Includes $3.8M US tax Cuts and Job Act Effect in 2017
Summary of Non-GAAP Financial Information | ||||||||||||
U.S. dollars in thousands (except per share amounts) | ||||||||||||
Three months ended | Twelve months ended | |||||||||||
December 31, | December 31, | |||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | |||||||||
Revenues | 72,448 | 100% | 57,113 | 100% | 272,003 | 100% | 216,190 | 100% | ||||
Gross profit | 29,517 | 40.7% | 23,850 | 41.8% | 106,667 | 39.2% | 91,767 | 42.4% | ||||
Operating profit | 9,059 | 12.5% | 7,493 | 13.1% | 23,113 | 8.5% | 29,615 | 13.7% | ||||
Net income to shareholders | 6,141 | 8.5% | 5,958 | 10.4% | 15,540 | 5.7% | 24,199 | 11.2% | ||||
Adjusted EBITDA | 10,076 | 13.9% | 8,298 | 14.5% | 26,935 | 9.9% | 32,450 | 15.0% | ||||
Basic earnings per share | 0.12 | 0.12 | 0.32 | 0.49 | ||||||||
Diluted earnings per share | 0.12 | 0.12 | 0.31 | 0.49 |
Non-GAAP Revenues by Geographic Breakdown | |||||||||
U.S. dollars in thousands | |||||||||
Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | |||||
North America | 31,580 | 32,780 | 28,544 | 19,465 | 21,107 | ||||
Europe & South Africa | 37,051 | 35,324 | 36,711 | 32,489 | 28,292 | ||||
APAC | 3,817 | 5,750 | 3,912 | 4,580 | 7,714 | ||||
Total | 72,448 | 73,854 | 69,167 | 56,534 | 57,113 |
Adjusted EBITDA Calculation | ||||||||
U.S. dollars in thousands | ||||||||
Three months ended | Year ended | |||||||
December 31, | December 31, | |||||||
2017 | 2016 | 2017 | 2016 | |||||
GAAP operating profit (loss) | 1,132 | 5,591 | 1,002 | 24,840 | ||||
Non-GAAP adjustments: | ||||||||
Amortization of capitalized software | 1,270 | 1,092 | 4,824 | 4,929 | ||||
Amortization of other intangible assets | 2,064 | 593 | 7,243 | 2,257 | ||||
Capitalization of software development | (1,236) | (1,091) | (5,567) | (5,545) | ||||
Stock-based compensation | 655 | 522 | 2,035 | 1,955 | ||||
Compensation related to acquisition and | 144 | 786 | 2,685 | 1,179 | ||||
Restructuring and cost reduction plan | 4,182 | - | 8,082 | - | ||||
Valuation adjustment on acquired | 848 | - | 2,809 | - | ||||
Non-GAAP operating profit | 9,059 | 7,493 | 23,113 | 29,615 | ||||
Depreciation | 1,017 | 805 | 3,822 | 2,835 | ||||
Adjusted EBITDA | 10,076 | 8,298 | 26,935 | 32,450 |
SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES | |||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||
U.S. Dollars in thousands | |||||
December 31, | December 31, | ||||
2017 | 2016 | ||||
(unaudited) | (unaudited) | ||||
ASSETS | |||||
CURRENT ASSETS | |||||
Cash and cash equivalents | 71,467 | 60,908 | |||
Trade receivables, net | 53,226 | 34,684 | |||
Other receivables and prepaid expenses | 6,280 | 6,389 | |||
Marketable securities | - | 18,220 | |||
Total current assets | 130,973 | 120,201 | |||
LONG-TERM ASSETS | |||||
Marketable securities | - | 17,228 | |||
Property and equipment, net | 10,695 | 9,807 | |||
Severance pay fund | 4,547 | 4,041 | |||
Goodwill and intangible assets, net | 221,403 | 101,951 | |||
Other long-term assets | 3,675 | 4,623 | |||
Total long-term assets | 240,320 | 137,650 | |||
TOTAL ASSETS | 371,293 | 257,851 | |||
LIABILITIES AND EQUITY | |||||
CURRENT LIABILITIES | |||||
Trade payables | 7,044 | 6,562 | |||
Accrued expenses and other liabilities | 46,277 | 32,049 | |||
Deferred revenue | 16,513 | 9,137 | |||
Total current liabilities | 69,834 | 47,748 | |||
LONG-TERM LIABILITIES | |||||
Other long-term liabilities | 15,451 | 9,864 | |||
Debenture | 78,281 | - | |||
Accrued severance pay | 5,500 | 4,940 | |||
Total long-term liabilities | 99,232 | 14,804 | |||
REDEEMABLE NON-CONTROLLING INTEREST | 1,353 | 908 | |||
EQUITY | 200,874 | 194,391 | |||
TOTAL LIABILITIES AND EQUITY | 371,293 | 257,851 |
SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES | ||
CONSOLIDATED STATEMENT OF CASH FLOW | ||
U.S. dollars in thousands | ||
Year ended | ||
December 31, | ||
2017 | 2016 | |
(unaudited) | (unaudited) | |
Cash flows from operating activities: | ||
Net income (loss) | 556 | 19,601 |
Reconciliation of net income (loss) to net cash provided by operating activities: | ||
Depreciation and amortization | 15,871 | 10,021 |
Amortization of premium, accrued interest and loss on sales of marketable | 509 | (516) |
Stock-based compensation related to options issued to employees | 2,270 | 1,955 |
Net changes in operating assets and liabilities, net of amount acquired: | ||
Trade receivables | (5,253) | (5,435) |
Deferred tax assets | (8,840) | 1,664 |
Other operating assets | 3,688 | (3,309) |
Trade payables | (1,388) | 1,101 |
Other operating liabilities | 118 | 2,223 |
Deferred revenues | 1,249 | (1,035) |
Severance pay | (37) | (231) |
Net cash provided by operating activities | 8,743 | 26,039 |
Cash flows from investing activities: | ||
Purchase of property and equipment | (2,622) | (4,664) |
Purchase of marketable securities, net of interest received | - | (9,017) |
Proceeds from sales of marketable securities | 35,369 | 13,898 |
Payments for business acquisition, net of cash acquired | (103,103) | (4,382) |
Capitalized software development costs | (5,567) | (5,545) |
Restricted cash | - | 1,393 |
Net cash used in investing activities | (75,923) | (8,317) |
Cash flows from financing activities: | ||
Proceeds from employee stock options exercised | 1,823 | 890 |
Payment to shareholders in respect of acquisition | - | (1,440) |
Loan received net of repayment of loan | - | (9,786) |
Issuance of debenture, net | 78,173 | - |
Repayment of loan | - | (824) |
Distribution of dividend | (9,851) | (73) |
Net cash provided by (used in) financing activities | 70,145 | (11,233) |
Effect of exchange rate changes on cash and cash equivalents | 7,594 | 68 |
Increase in cash and cash equivalents | 10,559 | 6,557 |
Cash and cash equivalents at the beginning of period | 60,908 | 54,351 |
Cash and cash equivalents at the end of period | 71,467 | 60,908 |
Debenture Covenants
As of December 31, 2017, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B debentures that it issued in September 2017, based on having achieved the following in its consolidated financial results:
Covenant 1
- Target shareholders' equity (excluding minority interest): above $120 million
- Actual shareholders' equity equal to $200 million
Covenant 2
- Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company's Series B debentures) bellow 65%
- Actual ratio of net financial indebtedness to net capitalization equal to (3.28)%.
Investors and Media Contact
Yaffa Cohen-Ifrah
Chief Marketing Officer and Head of Corporate Communications
Sapiens International
U.S. Mobile: +1 201-250-9414
Mobile: +972 54-9099039
Email: yaffa.cohen-ifrah@sapiens.com
View original content:http://www.prnewswire.com/news-releases/sapiens-reports-fourth-quarter-and-full-year-2017-financial-results-300610599.html
SOURCE Sapiens International Corporation
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Sapiens International Corporation NVShsmehr Nachrichten
Keine Nachrichten verfügbar. |